Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,434,830 papers from all fields of science
Search
Sign In
Create Free Account
ganstigmine
Known as:
(-)-O-((2'-ethylphenyl)carbamoyl)geneseroline hydrochloride
, (4AS,9AS)-2,3,4,4a,9,9a-Hexahydro-2,4a,9-Trimethyl-1,2-Oxazino(6,5-B)Indol-6-Yl O-Ethylcarbanilate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Alkaloids
Carbamates
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Lead optimization studies towards the discovery of novel carbamates as potent AChE inhibitors for the potential treatment of Alzheimer's disease.
K. Roy
,
Santoshkumar Tota
,
T. Tripathi
,
S. Chander
,
C. Nath
,
A. Saxena
Bioorganic & Medicinal Chemistry
2012
Corpus ID: 44706616
2007
2007
Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: an in vivo study.
L. Trabace
,
T. Cassano
,
+5 authors
V. Cuomo
Pharmacological Research
2007
Corpus ID: 12290114
2003
2003
Characterization of the effect of ganstigmine (CHF2819) on amyloid precursor protein metabolism in SH-SY5Y neuroblastoma cells
M. Mazzucchelli
,
E. Porrello
,
G. Villetti
,
C. Pietra
,
S. Govoni
,
M. Racchi
Journal of neural transmission
2003
Corpus ID: 25831662
Summary. We have investigated the effect of ganstigmine (CHF2819), a novel geneserine derived acetylcholinesterase (AChE…
Expand
2003
2003
Characterization of Ganstigmine metabolites in hepatocytes by low- and high-resolution mass spectrometry coupled with liquid chromatography.
N. Pelizzi
,
P. Puccini
,
B. Riccardi
,
D. Acerbi
,
S. Catinella
Rapid Communications in Mass Spectrometry
2003
Corpus ID: 43212834
In order to deepen the understanding of the metabolism of Ganstigmine, a new acetylcholinesterase inhibitor under evaluation for…
Expand
2003
2003
First Clinical Evaluation of Ganstigmine in Patients With Probable Alzheimer's Disease
S. Jhee
,
L. Fabbri
,
+6 authors
T. Shiovitz
Clinical neuropharmacology
2003
Corpus ID: 27163885
The objective of this study was to evaluate the safety, tolerability, maximum tolerated dose, pharmacokinetics, and…
Expand
Review
2003
Review
2003
Ganstigmine. Chiesi.
Anthony Johnson
Current opinion in investigational drugs
2003
Corpus ID: 38507821
Ganstigmine (CHF-2819) is being developed by Chiesi as a potential treatment for neurodegenerative and cognitive disorders. The…
Expand
Review
2002
Review
2002
Ganstigmine (CHF 2819).
Drugs in R&D
2002
Corpus ID: 36509752
2002
2002
Ganstigmine: pharmacological profile promising for Alzheimer's disease
2002
Corpus ID: 195127223
2001
2001
Phase I metabolism of ganstigmine. Rat, dog, monkey and human liver microsomal extracts investigated by liquid chromatography electrospray tandem mass spectrometry.
S. Catinella
,
N. Pelizzi
,
+4 authors
P. Ventura
Journal of Mass Spectrometry
2001
Corpus ID: 31319326
Ganstigmine, a new acetylcholinesterase inhibitor, was incubated with rat liver microsomes and the resulting metabolites were…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required